Partners HealthCare System and one of its hospitals, Brigham and Women’s Hospital, have agreed to pay $10 million to resolve allegations that a stem cell research lab fraudulently obtained federal grant funding, the US attorney’s office in Boston said Thursday.
The government had contended that the lab, run by Dr. Piero Anversa, included false scientific information in claims to the National Institutes of Health, federal prosecutors said in a statement.
“Individuals and institutions that receive research funding from NIH have an obligation to conduct their research honestly and not to alter results to conform with unproven hypotheses,” said acting U.S. Attorney William D. Weinreb.
“Medical research fraud not only wastes scarce government resources but also undermines the scientific process and the search for better treatments for serious diseases,” he said.
Anversa and two other doctors who were allegedly involved are no longer affiliated with Partners and the Brigham. Partners and the Brigham, after learning of the allegations, investigated — and disclosed them to federal authorities, federal prosecutors said.
“We commend Brigham and Women’s for self-disclosing the allegations of fraudulent research at the Anversa laboratory, and for taking steps to prevent future recurrences of such conduct,” Weinreb said.